Multifarious functions of the fragile x mental retardation protein, Trends Genet, vol.33, pp.703-717, 2017. ,
FMR1 protein: conserved RNP family domains and selective RNA binding, Science, vol.262, pp.563-569, 1993. ,
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein, Cell, vol.74, pp.291-299, 1993. ,
Kissing complex RNAs mediate interaction between the fragile-X mental retardation protein KH2 domain and brain polyribosomes, Genes Dev, vol.19, pp.903-921, 2005. ,
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function, Cell, vol.107, pp.489-99, 2001. ,
Human FMRP contains an integral tandem Agenet (tudor) and KH motif in the amino terminal domain, Hum Mol Genet, vol.24, pp.1733-1773, 2015. ,
The aminoterminal structure of human fragile X mental retardation protein obtained using precipitant-immobilized imprinted polymers, Nat Commun, vol.6, p.6634, 2015. ,
A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response, Cell, vol.157, pp.869-81, 2014. ,
FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association, Mol Cell, vol.1, pp.109-127, 1997. ,
Fragile balance: RNA editing tunes the synapse, Nat Neurosci, vol.14, pp.1492-1496, 2011. ,
The translation of translational control by FMRP: therapeutic targets for FXS, Nat Neurosci, vol.16, pp.1530-1536, 2013. ,
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism, Cell, vol.146, pp.247-61, 2011. ,
HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein, Nucleic Acids Res, vol.46, pp.6344-55, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02407981
Fragile X syndrome, Nat Rev Dis Prim, vol.3, p.17065, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01104162
The fragile X syndrome protein represses activitydependent translation through CYFIP1, a new 4E-BP, Cell, vol.134, pp.1042-54, 2008. ,
Phosphorylation influences the translation state of FMRPassociated polyribosomes, Hum Mol Genet, vol.12, pp.3295-305, 2003. ,
The fragile X syndrome protein FMRP associates with BC1 ,
, RNA and regulates the translation of specific mRNAs at synapses, Cell, vol.112, pp.317-344, 2003.
Fragile Xrelated protein and VIG associate with the RNA interference machinery, Genes Dev, vol.16, pp.2491-2497, 2002. ,
A drosophila fragile X protein interacts with components of RNAi and ribosomal proteins, Genes Dev, vol.16, pp.2497-508, 2002. ,
Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs, J Biomed Biotechnol, p.64347, 2006. ,
Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway, Nat Neurosci, vol.7, pp.113-120, 2004. ,
Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132, Neuron, vol.65, pp.373-84, 2010. ,
Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling, Mol Cell, vol.42, pp.673-88, 2011. ,
A novel function for fragile X mental retardation protein in translational activation, PLoS Biol, vol.7, p.16, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00357398
The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the fragile X mental retardation protein in cerebellum, Nucleic Acids Res, vol.43, pp.8540-50, 2015. ,
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals, Hum Mol Genet, vol.5, pp.1083-91, 1996. ,
Analysis of domains affecting intracellular localization of the FMRP protein, Neurobiol Dis, vol.4, pp.329-365, 1997. ,
Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes, J Neurosci, vol.17, pp.1539-1586, 1997. ,
The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding, Biochemistry, vol.42, pp.10437-10481, 2003. ,
The FMRP regulon: from targets to disease convergence, Front Neurosci, vol.7, p.191, 2013. ,
Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them, Mol Cell Biol, vol.16, pp.3825-3857, 1996. ,
Oligomerization properties of fragile-X mentalretardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P, Biochem J, vol.343, pp.517-540, 1999. ,
A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein, Hum Mol Genet, vol.8, pp.2557-66, 1999. ,
82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization, Hum Mol Genet, vol.12, pp.1689-98, 2003. ,
A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P, Proc Natl Acad Sci USA, vol.98, pp.8844-8853, 2001. ,
The fragile X mental retardation protein, Brain Res Bull, vol.56, pp.375-82, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-00172130
The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules, Hum Mol Genet, vol.16, pp.3047-58, 2007. ,
Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density, Nat Commun, vol.5, p.3628, 2014. ,
New insights into the role of Cav2 protein family in calcium flux deregulation in Fmr1-KO neurons, Front Mol Neurosci, vol.11, p.342, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02443567
The C terminus of fragile X mental retardation protein interacts with the multi-domain Ranbinding protein in the microtubule-organising centre, J Mol Biol, vol.343, pp.43-53, 2004. ,
The nuclear microspherule protein 58 is a novel RNAbinding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons, Hum Mol Genet, vol.15, pp.1525-1563, 2006. ,
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome, Cell, vol.65, pp.905-919, 1991. ,
Adult fragile X syndrome. Clinico-neuropathologic findings, Acta Neuropathol, vol.67, pp.289-95, 1985. ,
Analysis of neocortex in three males with the fragile X syndrome, Am J Med Genet, vol.41, pp.289-94, 1991. ,
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination, Am J Med Genet, vol.98, pp.161-168, 2001. ,
Synaptic actin dysregulation, a convergent mechanism of mental disorders?, J Neurosci, vol.36, pp.11411-11418, 2016. ,
Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines, Brain Res, vol.1084, pp.158-64, 2006. ,
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian fragile X consortium, Cell, vol.78, pp.23-33, 1994. ,
The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo, Neurobiol Dis, vol.21, pp.549-55, 2006. ,
Altered synaptic plasticity in a mouse model of fragile X mental retardation, Proc Natl Acad Sci USA, vol.99, pp.7746-50, 2002. ,
The mGluR theory of fragile X mental retardation, Trends Neurosci, vol.27, pp.370-377, 2004. ,
The next level of complexity: crosstalk of posttranslational modifications, Proteomics, vol.14, pp.513-537, 2014. ,
Post-translational modification of p53 in tumorigenesis, Nat Rev Cancer, vol.4, pp.793-805, 2004. ,
Post-translational modifications of tau protein: implications for Alzheimer's disease, Neurochem Int, vol.58, pp.458-71, 2011. ,
PTMD: a database of human disease-associated post-translational modifications, Genomics, Proteom Bioinform, vol.16, pp.244-51, 2018. ,
Posttranslational modifications of Parkinson's disease-related proteins: phosphorylation, sumoylation and ubiquitination, Biochim Biophys Acta Mol Basis Dis, vol.1865, pp.2001-2008, 2019. ,
Casein kinase II phosphorylates the fragile X mental retardation protein and modulates its biological properties, Mol Cell Biol, vol.22, pp.8438-8485, 2002. ,
Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression, Neuron, vol.51, pp.441-54, 2006. ,
Identification and characterization of the methyl arginines in the fragile X mental retardation protein Fmrp, Hum Mol Genet, vol.15, pp.87-96, 2006. ,
Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation, Nat Commun, vol.9, p.757, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02443557
Chemical induction of mGluR5-and protein synthesis-dependent long-term depression in hippocampal area CA1, J Neurophysiol, vol.86, pp.321-326, 2001. ,
Routes, destinations and delays: recent advances in AMPA receptor trafficking, Trends Neurosci, vol.34, pp.258-68, 2011. ,
The role of AMPA receptors in postsynaptic mechanisms of synaptic plasticity, Front Cell Neurosci, vol.8, p.401, 2014. ,
Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression, Science, vol.288, pp.1254-1261, 2000. ,
Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation, Proc Natl Acad Sci USA, vol.94, pp.5395-400, 1997. ,
Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses, J Neurosci, vol.24, pp.2648-55, 2004. ,
Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors, Brain Res Mol Brain Res, vol.110, pp.267-78, 2003. ,
Dual regulation of fragile X mental retardation protein by group I metabotropic glutamate receptors controls translation-dependent epileptogenesis in the hippocampus, J Neurosci, vol.31, pp.725-759, 2011. ,
A Cdh1-APC/ FMRP ubiquitin signaling link drives mGluR-dependent synaptic plasticity in the mammalian brain, Neuron, vol.86, pp.726-765, 2015. ,
Fragile X mental retardation protein determinants required for its association with polyribosomal mRNPs, Hum Mol Genet, vol.12, pp.3087-96, 2003. ,
FMRP phosphorylation reveals an immediateearly signaling pathway triggered by group I mGluR and mediated by PP2A, J Neurosci, vol.27, pp.14349-57, 2007. ,
Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression, J Neurosci, vol.72, pp.5924-5960, 2012. ,
Bidirectional regulation of fragile X mental retardation protein phosphorylation controls rhodopsin homoeostasis, J Mol Cell Biol, vol.9, pp.104-120, 2017. ,
S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade, J Biol Chem, vol.283, pp.18478-82, 2008. ,
Epidermal growth factor-mediated activation of an S6 kinase in Swiss mouse 3T3 cells, J Biol Chem, vol.260, pp.10314-10323, 1985. ,
Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt, J Biol Chem, vol.280, pp.36029-36065, 2005. ,
Tuberous sclerosis, Lancet, vol.372, pp.657-68, 2008. ,
FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity, PLoS ONE, vol.9, p.96956, 2014. ,
Mammalian FMRP S499 is phosphorylated by CK2 and promotes secondary phosphorylation of, FMRP. eNeuro, vol.3, pp.1-16, 2016. ,
Assessment of CK2 constitutive activity in cancer cells, Methods Enzymol, vol.484, pp.495-514, 2010. ,
Systematic investigation of hierarchical phosphorylation by protein kinase CK2, J Proteom, vol.118, pp.49-62, 2015. ,
Phosphorylation of FMRP inhibits association with Dicer, RNA, vol.15, pp.362-368, 2009. ,
Splice formdependent regulation of axonal arbor complexity by FMRP, Dev Neurobiol, vol.77, pp.738-52, 2017. ,
In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation, Hum Mol Genet, vol.21, pp.900-915, 2012. ,
Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation, J Neurosci, vol.32, pp.2582-2589, 2012. ,
Mutations of PQBP1 in Renpenning syndrome promote ubiquitin-mediated degradation of FMRP and cause synaptic dysfunction, Hum Mol Genet, vol.26, pp.955-68, 2017. ,
Regulation of fragile X mental retardation 1 protein by C-terminus of Hsc70-interacting protein depends on its phosphorylation status, Biochem Biophys Res Commun, vol.453, pp.192-199, 2014. ,
Developmental regulation and spatiotemporal redistribution of the sumoylation machinery in the rat central nervous system, PLoS ONE, vol.7, p.33757, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00855016
Activity-dependent regulation of the sumoylation machinery in rat hippocampal neurons, Biol Cell, vol.105, pp.30-45, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00855030
The synaptic balance between sumoylation and desumoylation is maintained by the activation of metabotropic mGlu5 receptors, Cell Mol Life Sci, vol.76, pp.3019-3050, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02408725
Protein sumoylation in brain development, neuronal morphology and spinogenesis, Neuromolecular Med, vol.15, pp.677-91, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00855033
Sumoylation in synaptic function and dysfunction, Front Synaptic Neurosci, vol.8, p.9, 2016. ,
Extranuclear sumoylation in neurons, Trends Neurosci, vol.41, pp.198-210, 2018. ,
mGlu5 receptors regulate synaptic sumoylation via a transient PKC-dependent diffusional trapping of Ubc9 into spines, Nat Commun, vol.5, p.5113, 2014. ,
Protein arginine methylation in mammals: who, what, and why, Mol Cell, vol.33, pp.1-13, 2009. ,
Arginine methylation: the coming of age, Mol Cell, vol.65, pp.8-24, 2017. ,
Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation, J Biol Chem, vol.286, pp.44424-44456, 2011. ,
Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4, Genes Dev, vol.26, pp.2749-62, 2012. ,
PRMT1 and PRMT8 regulate retinoic acid-dependent neuronal differentiation with implications to neuropathology, Stem Cells, vol.33, pp.726-767, 2015. ,
Fukamizu A. Severe hypomyelination and developmental defects are caused in mice lacking protein arginine methyltransferase 1 (PRMT1) in the central nervous system, J Biol Chem, vol.291, pp.2237-2282, 2016. ,
PRMT5-mediated regulation of developmental myelination, Nat Commun, vol.9, p.2840, 2018. ,
In vivo and in vitro arginine methylation of RNA-binding proteins, Mol Cell Biol, vol.15, pp.2800-2808, 1995. ,
Arginine methylation of a glycine and arginine rich peptide derived from sequences of human FMRP and fibrillarin, Proc Natl Sci Counc, vol.23, pp.175-80, 1999. ,
Alternative splicing modulates protein arginine methyltransferase-dependent methylation of fragile X syndrome mental retardation protein, Biochemistry, vol.45, pp.10385-93, 2006. ,
Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA, Hum Mol Genet, vol.19, pp.1314-1337, 2010. ,
Methylation of the arginine-glycine-rich region in the fragile X mental retardation protein FMRP differentially affects RNA binding, Cell Mol Biol Lett, vol.7, pp.877-83, 2002. ,
Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP, J Cell Sci, vol.119, pp.1933-1979, 2006. ,
Regulating a translational regulator: mechanisms cells use to control the activity of the fragile X mental retardation protein, Cell Mol Life Sci, vol.61, pp.1714-1742, 2004. ,
GABAAergic stimulation modulates intracellular protein arginine methylation, Neurosci Lett, vol.572, pp.38-43, 2014. ,
Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome, J Neurosci, vol.30, pp.9929-9967, 2010. ,
Chemical and structural probing of the N-terminal residues encoded by FMR1 exon 15 and their effect on downstream arginine methylation, Biochemistry, vol.47, pp.8491-503, 2008. ,
Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation, Proc Natl Acad Sci, vol.116, pp.4218-4245, 2019. ,
The roles of post-translational modifications on alpha-synuclein in the pathogenesis of Parkinson's diseases, Front Neurosci, vol.13, p.381, 2019. ,
ACMG standards and guidelines for fragile X testing: a revision to the disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the American College of Medical Genetics and Genomics, Genet Med, vol.15, pp.575-86, 2013. ,
Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males, Am J Med Genet A, vol.152, pp.2512-2532, 2010. ,
Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype, PLoS ONE, vol.5, p.9476, 2010. ,
Rare FMR1 gene mutations causing fragile X syndrome: a review, Am J Med Genet A, vol.176, pp.11-19, 2018. ,
Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to fragile-X syndrome, Eur J Hum Genet, vol.25, pp.423-454, 2017. ,
A point mutation in the FMR-1 gene associated with fragile X mental retardation, Nat Genet, vol.3, pp.31-36, 1993. ,
A mouse model of the human fragile X syndrome I304N mutation, PLoS Genet, vol.5, p.1000758, 2009. ,
Fragile X syndrome due to a missense mutation, Eur J Hum Genet, vol.22, pp.1185-1194, 2014. ,
Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures, Proc Natl Acad Sci, vol.112, pp.949-56, 2015. ,
Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening, Mol Cell Probes, vol.28, pp.279-83, 2014. ,
Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability, Am J Med Genet, vol.84, pp.184-90, 1999. ,
Screening for fragile X syndrome: results from a school for mentally retarded children, Acta Paediatr, vol.91, pp.535-544, 2002. ,
Prevalence of the fragile X syndrome in Yugoslav patients with non-specific mental retardation, J Neurogenet, vol.17, pp.223-253, 2003. ,
Five years of molecular diagnosis of Fragile X syndrome (1997-2001): a collaborative study reporting 95% of the activity in France, Am J Med Genet A, vol.129, pp.218-242, 2004. ,
Presentation of a recurrent FMR1 missense mutation (R138Q) in an affected female, Transl Sci Rare Dis, vol.3, pp.139-183, 2018. ,
From FMRP function to potential therapies for fragile X syndrome, Neurochem Res, vol.39, pp.1016-1047, 2014. ,
Therapeutic strategies in fragile X syndrome: from bench to bedside and back, Neurotherapeutics, vol.12, pp.584-608, 2015. ,
The search for an effective therapy to treat fragile X syndrome: dream or reality? Front Synaptic Neurosci, vol.9, p.15, 2017. ,
KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar ataxia 13 displays aberrant intracellular trafficking, Neurobiol Dis, vol.71, pp.270-279, 2014. ,
Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome, Cell, vol.77, pp.33-42, 1994. ,
Evidence that fragile X mental retardation protein is a negative regulator of translation, Hum Mol Genet, vol.10, pp.329-367, 2001. ,
The role of a clinically important mutation in the fold and RNA-binding properties of KH motifs, RNA, vol.9, pp.293-301, 2003. ,
The design and delivery of a PKA inhibitory polypeptide to treat SCA1, J Neurochem, vol.131, pp.101-115, 2014. ,
Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1, Cell, vol.113, pp.457-68, 2003. ,
Phosphorylation of ATXN1 at Ser776 in the cerebellum, J Neurochem, vol.110, pp.675-86, 2009. ,
SUMOylation of synapsin Ia maintains synaptic vesicle availability and is reduced in an autism mutation, Nat Commun, vol.6, p.7728, 2015. ,
MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome, Nat Commun, vol.7, p.10552, 2016. ,
SUMO and the robustness of cancer, Nat Rev Cancer, vol.17, pp.184-97, 2017. ,
Sumoylation: implications for neurodegenerative diseases, Adv Exp Med Biol, vol.963, pp.261-81, 2017. ,
Roles of sumoylation in heart development and cardiovascular diseases, Curr Mol Med, vol.16, pp.877-84, 2017. ,
Smallmolecule inhibitors targeting protein sumoylation as novel anticancer compounds, Mol Pharm, vol.94, pp.885-94, 2018. ,
Smallmolecule activation of SERCA2a SUMOylation for the treatment of heart failure, Nat Commun, vol.6, p.7229, 2015. ,
Drugging sumoylation for neuroprotection and oncotherapy, Neural Regen Res, vol.13, pp.415-421, 2018. ,
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study, Blood Adv, vol.3, pp.508-526, 2019. ,
Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer, Oncology, vol.20, pp.1415-1421, 1410. ,
Topoisomerase I inhibitors: camptothecins and beyond, Nat Rev Cancer, vol.6, pp.789-802, 2006. ,
A novel quantitative high-throughput screen identifies drugs that both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and facilitate neuroprotection in a model of oxygen and glucose deprivation, J Cereb Blood Flow Metab, vol.36, pp.426-467, 2016. ,
Advances in the development of SUMO specific protease (SENP) inhibitors, Comput Struct Biotechnol J, vol.13, pp.204-215, 2015. ,
Targeting the SUMO pathway for neuroprotection in brain ischaemia, Stroke Vasc Neurol, vol.1, pp.101-108, 2016. ,
Ginkgolic acid inhibits protein sumoylation by blocking formation of the E1-SUMO intermediate, Chem Biol, vol.16, pp.133-173, 2009. ,
Kerriamycin B inhibits protein sumoylation, J Antibiot, vol.62, pp.221-225, 2009. ,
Inhibition of protein sumoylation by davidiin, an ellagitannin from Davidia involucrata, J Antibiot, vol.67, pp.335-343, 2014. ,
An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation, Chem Biol, vol.20, pp.604-617, 2013. ,
A small-molecule microarray approach for the identification of E2 enzyme inhibitors in ubiquitin-like conjugation pathways, vol.22, pp.760-766, 2017. ,
Topotecan is a potent inhibitor of sumoylation in glioblastoma multiforme and alters both cellular replication and metabolic programming, Sci Rep, vol.7, p.7425, 2017. ,
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy, Oncologist, vol.8, pp.508-521, 2003. ,
Dysregulation of fragile x mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain study, Mol Autism, vol.2, issue.6, 2011. ,
Phosphorylated fragile X mental retardation protein at serine 499, is reduced in cerebellar vermis and superior frontal cortex of subjects with autism: implications for fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling, Mol Autism, vol.4, p.41, 2013. ,
Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?, Mol Autism, vol.4, p.15, 2013. ,
Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism, Anat Rec (Hoboken), vol.294, pp.1635-1680, 2011. ,
A review of fragile X premutation disorders: expanding the psychiatric perspective, J Clin Psychiatry, vol.70, pp.852-62, 2009. ,
Fragile X mental retardation protein levels are decreased in major psychiatric disorders, Schizophr Res, vol.124, pp.246-253, 2010. ,
Contrast, motion, perceptual integration, and neurocognition in schizophrenia: the role of fragile-X related mechanisms, Prog Neuropsychopharmacol Biol Psychiatry, vol.46, pp.92-97, 2013. ,
Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia, Psychiatry Res, vol.210, pp.690-693, 2013. ,